Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-1-11
pubmed:abstractText
To deliver rapid isoniazid (INH) and rifampicin (RMP) drug susceptibility testing (DST) close to the patient, we designed a decentralisation process for the microscopic observation drug susceptibility (MODS) assay in Peru and evaluated its reliability.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-10699023, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-12234129, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-12454186, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-15472289, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-17035648, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-17251409, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-17278058, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18000545, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18284841, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18300380, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18695217, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18698423, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-19742330, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-20192726, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-20202307, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-20351778, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-20937190
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1815-7920
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
217-22, i
pubmed:dateRevised
2011-11-10
pubmed:meshHeading
pubmed-meshheading:21219684-Accreditation, pubmed-meshheading:21219684-Antitubercular Agents, pubmed-meshheading:21219684-Clinical Laboratory Techniques, pubmed-meshheading:21219684-Humans, pubmed-meshheading:21219684-Isoniazid, pubmed-meshheading:21219684-Microbial Sensitivity Tests, pubmed-meshheading:21219684-Microscopy, pubmed-meshheading:21219684-Mycobacterium tuberculosis, pubmed-meshheading:21219684-Observer Variation, pubmed-meshheading:21219684-Peru, pubmed-meshheading:21219684-Predictive Value of Tests, pubmed-meshheading:21219684-Regional Health Planning, pubmed-meshheading:21219684-Reproducibility of Results, pubmed-meshheading:21219684-Rifampin, pubmed-meshheading:21219684-Sensitivity and Specificity, pubmed-meshheading:21219684-Sputum, pubmed-meshheading:21219684-Tuberculosis, Multidrug-Resistant
pubmed:year
2011
pubmed:articleTitle
Reliability of the MODS assay decentralisation process in three health regions in Peru.
pubmed:affiliation
Centro Nacional de Salud Pública, Instituto Nacional de Salud de Perú, Lima, Peru. mendozalberto@hotmail.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Evaluation Studies